130 related articles for article (PubMed ID: 38512670)
1. Regulation of tau by peptidyl-prolyl isomerases.
Zhuang S; Chakraborty P; Zweckstetter M
Curr Opin Struct Biol; 2024 Feb; 84():102739. PubMed ID: 38061261
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Methylation and Phosphorylation Stoichiometry.
Ayoub CA; Moore KI; Kuret J
Methods Mol Biol; 2024; 2754():221-235. PubMed ID: 38512670
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.
Huseby CJ; Hoffman CN; Cooper GL; Cocuron JC; Alonso AP; Thomas SN; Yang AJ; Kuret J
J Alzheimers Dis; 2019; 71(3):979-991. PubMed ID: 31450505
[TBL] [Abstract][Full Text] [Related]
4. Degradation or aggregation: the ramifications of post-translational modifications on tau.
Park S; Lee JH; Jeon JH; Lee MJ
BMB Rep; 2018 Jun; 51(6):265-273. PubMed ID: 29661268
[TBL] [Abstract][Full Text] [Related]
5. A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
García-Escudero V; Ruiz-Gabarre D; Gargini R; Pérez M; García E; Cuadros R; Hernández IH; Cabrera JR; García-Escudero R; Lucas JJ; Hernández F; Ávila J
Acta Neuropathol; 2021 Jul; 142(1):159-177. PubMed ID: 33934221
[TBL] [Abstract][Full Text] [Related]
6. FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease.
Mair W; Muntel J; Tepper K; Tang S; Biernat J; Seeley WW; Kosik KS; Mandelkow E; Steen H; Steen JA
Anal Chem; 2016 Apr; 88(7):3704-14. PubMed ID: 26877193
[TBL] [Abstract][Full Text] [Related]
7. Tauopathies.
Hernández F; Avila J
Cell Mol Life Sci; 2007 Sep; 64(17):2219-33. PubMed ID: 17604998
[TBL] [Abstract][Full Text] [Related]
8. Methylation at a conserved lysine residue modulates tau assembly and cellular functions.
Shams H; Matsunaga A; Ma Q; Mofrad MRK; Didonna A
Mol Cell Neurosci; 2022 May; 120():103707. PubMed ID: 35231567
[TBL] [Abstract][Full Text] [Related]
9. Structure-based classification of tauopathies.
Shi Y; Zhang W; Yang Y; Murzin AG; Falcon B; Kotecha A; van Beers M; Tarutani A; Kametani F; Garringer HJ; Vidal R; Hallinan GI; Lashley T; Saito Y; Murayama S; Yoshida M; Tanaka H; Kakita A; Ikeuchi T; Robinson AC; Mann DMA; Kovacs GG; Revesz T; Ghetti B; Hasegawa M; Goedert M; Scheres SHW
Nature; 2021 Oct; 598(7880):359-363. PubMed ID: 34588692
[TBL] [Abstract][Full Text] [Related]
10. The AD tau core spontaneously self-assembles and recruits full-length tau to filaments.
Carlomagno Y; Manne S; DeTure M; Prudencio M; Zhang YJ; Hanna Al-Shaikh R; Dunmore JA; Daughrity LM; Song Y; Castanedes-Casey M; Lewis-Tuffin LJ; Nicholson KA; Wszolek ZK; Dickson DW; Fitzpatrick AWP; Petrucelli L; Cook CN
Cell Rep; 2021 Mar; 34(11):108843. PubMed ID: 33730588
[TBL] [Abstract][Full Text] [Related]
11. Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies.
Silva MC; Haggarty SJ
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255694
[TBL] [Abstract][Full Text] [Related]
12. A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications.
Drepper F; Biernat J; Kaniyappan S; Meyer HE; Mandelkow EM; Warscheid B; Mandelkow E
J Biol Chem; 2020 Dec; 295(52):18213-18225. PubMed ID: 33106314
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
